foscarnet has been researched along with Electrolytes in 3 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Electrolytes: Substances that dissociate into two or more ions, to some extent, in water. Solutions of electrolytes thus conduct an electric current and can be decomposed by it (ELECTROLYSIS). (Grant & Hackh's Chemical Dictionary, 5th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Adverse effects, such as decreased haemoglobin, decreased renal function and increased serum calcium, were observed in a few patients only." | 5.27 | Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. ( Ahlmén, J; Klintmalm, G; Lernestedt, JO; Lönnqvist, B; Paulin, T; Ringdén, O; Wahren, B, 1986) |
| " Adverse effects, such as decreased haemoglobin, decreased renal function and increased serum calcium, were observed in a few patients only." | 1.27 | Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. ( Ahlmén, J; Klintmalm, G; Lernestedt, JO; Lönnqvist, B; Paulin, T; Ringdén, O; Wahren, B, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ota, R | 1 |
| Hirata, A | 1 |
| Jayaweera, D | 1 |
| White, G | 1 |
| Moreno, J | 1 |
| Ringdén, O | 1 |
| Lönnqvist, B | 1 |
| Paulin, T | 1 |
| Ahlmén, J | 1 |
| Klintmalm, G | 1 |
| Wahren, B | 1 |
| Lernestedt, JO | 1 |
3 other studies available for foscarnet and Electrolytes
| Article | Year |
|---|---|
Relationship between renal dysfunction and electrolyte abnormalities in hematopoietic stem cell transplant patients treated with foscarnet.
Topics: Adult; Aged; Antiviral Agents; Creatinine; Cytomegalovirus Infections; Electrolytes; Female; Foscarn | 2021 |
Pre-treatment with hydration and electrolytes may prevent dose limiting toxicities during foscarnet induction therapy.
Topics: Antiviral Agents; Cytomegalovirus Retinitis; Electrolytes; Foscarnet; Humans; Premedication; Prospec | 1995 |
Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients.
Topics: Adult; Aged; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Electrolytes | 1986 |